Cargando…

1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital

BACKGROUND: Current IDSA guidelines recommend targeting a vancomycin trough between 15 and 20 mg/L to achieve an AUC/MIC ≥ 400; however, recent literature shows increased rates of nephrotoxicity within this range and the target AUC/MIC ratio may be achieved with lower troughs. We sought to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Seddon, Megan, Scorgie, Kevin, Kutner, Sara, McMahon, Andre, Kisgen, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253667/
http://dx.doi.org/10.1093/ofid/ofy210.1246
_version_ 1783373549499580416
author Seddon, Megan
Scorgie, Kevin
Kutner, Sara
McMahon, Andre
Kisgen, Jamie
author_facet Seddon, Megan
Scorgie, Kevin
Kutner, Sara
McMahon, Andre
Kisgen, Jamie
author_sort Seddon, Megan
collection PubMed
description BACKGROUND: Current IDSA guidelines recommend targeting a vancomycin trough between 15 and 20 mg/L to achieve an AUC/MIC ≥ 400; however, recent literature shows increased rates of nephrotoxicity within this range and the target AUC/MIC ratio may be achieved with lower troughs. We sought to determine whether a vancomycin AUC-based dosing protocol and spreadsheet-based calculator, using one-compartment population-based dosing and two steady-state serum levels, accurately predicted AUC/MIC ratio in patients with moderate to severe Staphylococcus aureus infections. METHODS: A retrospective analysis of 60 adult patients treated with vancomycin for culture-confirmed S. aureus was conducted. The primary outcome was percent of patients who met the AUC/MIC goal of ≥400. Secondary outcomes included: mean initial trough concentration in patients who met the AUC/MIC goal compared with those who did not; correlation of two different methods of AUC-estimation with the patient’s actual AUC; percentage of patients meeting AUC/MIC goal stratified by initial trough concentrations, age, weight, and indication; and percentage of patients meeting the AUC goal stratified by the same variables. Results were analyzed using descriptive statistics and calculations were performed using SPSS. RESULTS: The median age (range) was 55 (22–86) and 52% were male. Eighty-three percent of patients achieved an initial AUC/MIC ≥ 400, including 93% with serum troughs between 10 and 14.9 mg/L. Patients who met the AUC/MIC goal had an average trough of 13.5 mg/L, whereas those who did not had an average trough of 7.8 mg/L (P < 0.001). AUC estimation using population pharmacokinetics was significantly correlated with actual AUC (P = 0.011); however, this was not a strong correlation (r = 0.340). Subgroup analysis based on age, weight, and indication identified areas for improvement in the empiric dosing protocol at our institution. CONCLUSION: Use of the vancomycin AUC-based dosing protocol and calculator resulted in achievement of efficacy goal in the majority of patients, including many with vancomycin troughs between 10 and 15 mg/L. More accurate estimation of AUC and other pharmacokinetic variables using local patient data is important for improving the reliability of vancomycin dosing protocols. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253667
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62536672018-11-28 1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital Seddon, Megan Scorgie, Kevin Kutner, Sara McMahon, Andre Kisgen, Jamie Open Forum Infect Dis Abstracts BACKGROUND: Current IDSA guidelines recommend targeting a vancomycin trough between 15 and 20 mg/L to achieve an AUC/MIC ≥ 400; however, recent literature shows increased rates of nephrotoxicity within this range and the target AUC/MIC ratio may be achieved with lower troughs. We sought to determine whether a vancomycin AUC-based dosing protocol and spreadsheet-based calculator, using one-compartment population-based dosing and two steady-state serum levels, accurately predicted AUC/MIC ratio in patients with moderate to severe Staphylococcus aureus infections. METHODS: A retrospective analysis of 60 adult patients treated with vancomycin for culture-confirmed S. aureus was conducted. The primary outcome was percent of patients who met the AUC/MIC goal of ≥400. Secondary outcomes included: mean initial trough concentration in patients who met the AUC/MIC goal compared with those who did not; correlation of two different methods of AUC-estimation with the patient’s actual AUC; percentage of patients meeting AUC/MIC goal stratified by initial trough concentrations, age, weight, and indication; and percentage of patients meeting the AUC goal stratified by the same variables. Results were analyzed using descriptive statistics and calculations were performed using SPSS. RESULTS: The median age (range) was 55 (22–86) and 52% were male. Eighty-three percent of patients achieved an initial AUC/MIC ≥ 400, including 93% with serum troughs between 10 and 14.9 mg/L. Patients who met the AUC/MIC goal had an average trough of 13.5 mg/L, whereas those who did not had an average trough of 7.8 mg/L (P < 0.001). AUC estimation using population pharmacokinetics was significantly correlated with actual AUC (P = 0.011); however, this was not a strong correlation (r = 0.340). Subgroup analysis based on age, weight, and indication identified areas for improvement in the empiric dosing protocol at our institution. CONCLUSION: Use of the vancomycin AUC-based dosing protocol and calculator resulted in achievement of efficacy goal in the majority of patients, including many with vancomycin troughs between 10 and 15 mg/L. More accurate estimation of AUC and other pharmacokinetic variables using local patient data is important for improving the reliability of vancomycin dosing protocols. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253667/ http://dx.doi.org/10.1093/ofid/ofy210.1246 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Seddon, Megan
Scorgie, Kevin
Kutner, Sara
McMahon, Andre
Kisgen, Jamie
1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital
title 1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital
title_full 1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital
title_fullStr 1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital
title_full_unstemmed 1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital
title_short 1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital
title_sort 1415. implementation and validation of a vancomycin auc/mic calculator and dosing protocol at a large community hospital
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253667/
http://dx.doi.org/10.1093/ofid/ofy210.1246
work_keys_str_mv AT seddonmegan 1415implementationandvalidationofavancomycinaucmiccalculatoranddosingprotocolatalargecommunityhospital
AT scorgiekevin 1415implementationandvalidationofavancomycinaucmiccalculatoranddosingprotocolatalargecommunityhospital
AT kutnersara 1415implementationandvalidationofavancomycinaucmiccalculatoranddosingprotocolatalargecommunityhospital
AT mcmahonandre 1415implementationandvalidationofavancomycinaucmiccalculatoranddosingprotocolatalargecommunityhospital
AT kisgenjamie 1415implementationandvalidationofavancomycinaucmiccalculatoranddosingprotocolatalargecommunityhospital